Training session 09b - How to start a biotech company - was held online due to the COVID-19 sanitary crisis.

Training session 09a - Designing, developing and commercialising a ubiquitin system drug discovery service - was held online due to the COVID-19 sanitary crisis.

Whiteboard animation - CR8 is a novel molecular glue degrader. With the participation of Zuzanna Kozicka (FMI - Thomä lab)

Training session 02 - Cell biological methodologies to study protein ubiquitylation - was held online due to the COVID-19 sanitary crisis.

Our UbiCODE annual Symposium "Writing and editing the Ubiquitin code" was held in Bilbao.

Training session 09c - Grant writing from PhD to scientific leadership - was held online due to the COVID-19 sanitary crisis.

Training session 09a - Multidisciplinary drug discovery projects - was held online due to the COVID-19 sanitary crisis.

Our third Supervisory Board meeting was held virtually, due to the exceptional sanitary situation.

Paper breakdown - how to identify new molecular glue degraders. With the participation of Zuzanna Kozicka (FMI - Thomä lab)

Our second Supervisory Board meeting was held in Bilbao, Spain.

Training session 05 (Peptide and protein synthesis) and 06 (Mass spectrometry) was held in Leiden, Netherlands.

Training session 01 on SUMOylation and Ubiquitylation was held in Mainz, Germany.

Our UbiCODE annual Symposium "Druggabillity of the Ubiquitin system - which road to take?" was held in Lisbon.

Visit the Symposium website

Maria Gonzalez Santamarta (CNRSa) presented her work as part of the European Researchers' Night in Madrid, Spain.

UbiCODE's first training session (Crosstalk between Ub family members under stress conditions) was held in Valencia.

Our first Supervisory Board meeting was held in Lisbon, Portugal.

Our Kick-off meeting took place in Toulouse.

Communication activity. UbiCODE members participated in the Symposium Ubiquitin Family and Cancer organised in Toulouse.